Advanced Accelerator Applications S.A. Net Profit Margin

Net Profit Margin of AAAP for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Profit Margin growth rates and interactive chart. The net profit margin is equal to how much net income or profit is generated as a percentage of revenue. Net profit margin is the ratio of net profits (or net income) to revenues for a company. Net profit margin is typically expressed as a percentage. The net profit margin illustrates how much of each dollar in revenue collected by a company translates into profit.


Highlights and Quick Summary

  • Net Profit Margin for the quarter ending September 29, 2017 was -61.06% (a 124.98% increase compared to previous quarter)
  • Year-over-year quarterly Net Profit Margin increased by 14.52%
  • Annual Net Profit Margin for 2016 was -23.14% (a 20.58% increase from previous year)
  • Annual Net Profit Margin for 2015 was -19.19% (a 41.1% increase from previous year)
  • Twelve month Net Profit Margin ending September 29, 2017 was -44.15% (a 29.55% increase compared to previous quarter)
  • Twelve month trailing Net Profit Margin increased by 90.8% year-over-year
Trailing Net Profit Margin for the last four month:
29 Sep '17 29 Jun '17 30 Mar '17 30 Dec '16
-44.15% -34.08% -29.13% -23.14%
Visit stockrow.com/AAAP for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Profit Margin of Advanced Accelerator Applications S.A.

Most recent Net Profit Marginof AAAP including historical data for past 10 years.

Interactive Chart of Net Profit Margin of Advanced Accelerator Applications S.A.

Advanced Accelerator Applications S.A. Net Profit Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2017 -61.06% -27.14% -34.56%
2016 -53.32% -23.36% -5.18% -11.06% -23.14%
2015 -7.85% -19.19%
2014 -13.6%

Business Profile of Advanced Accelerator Applications S.A.

Sector: Medical
Industry: Drugs